title: Predicting individual responses to pravastatin using a physiologically based kinetic model for plasma cholesterol concentrations.
abstract: We used a previously developed physiologically based kinetic (PBK) model to analyze the effect of individual variations in metabolism and transport of cholesterol on pravastatin response. The PBK model is based on kinetic expressions for 21 reactions that interconnect eight different body cholesterol pools including plasma HDL and non-HDL cholesterol. A pravastatin pharmacokinetic model was constructed and the simulated hepatic pravastatin concentration was used to modulate the reaction rate constant of hepatic free cholesterol synthesis in the PBK model. The integrated model was then used to predict plasma cholesterol concentrations as a function of pravastatin dose. Predicted versus observed values at 40 mg/d pravastatin were 15 versus 22 % reduction of total plasma cholesterol, and 10 versus 5.6 % increase of HDL cholesterol. A population of 7,609 virtual subjects was generated using a Monte Carlo approach, and the response to a 40 mg/d pravastatin dose was simulated for each subject. Linear regression analysis of the pravastatin response in this virtual population showed that hepatic and peripheral cholesterol synthesis had the largest regression coefficients for the non-HDL-C response. However, the modeling also showed that these processes alone did not suffice to predict non-HDL-C response to pravastatin, contradicting the hypothesis that people with high cholesterol synthesis rates are good statin responders. In conclusion, we have developed a PBK model that is able to accurately describe the effect of pravastatin treatment on plasma cholesterol concentrations and can be used to provide insight in the mechanisms behind individual variation in statin response.
authors.affiliation: The Netherlands Organization for Applied Scientific Research (TNO), Utrechtseweg 48, P.O. Box 360, 3700 AJ, Zeist, The Netherlands.
authors.forename: Niek C A
authors.initials: NC
authors.lastname: van de Pas
authors.forename: Johan A C
authors.initials: JA
authors.lastname: Rullmann
authors.forename: Ruud A
authors.initials: RA
authors.lastname: Woutersen
authors.forename: Ben
authors.initials: B
authors.lastname: van Ommen
authors.forename: Ivonne M C M
authors.initials: IM
authors.lastname: Rietjens
authors.forename: Albert A
authors.initials: AA
authors.lastname: de Graaf
mesh_terms: D000465:Algorithms; D000924:Anticholesteremic Agents / Q000493:pharmacokinetics* / Q000494:pharmacology*; D002784:Cholesterol / Q000097:blood*; D008076:Cholesterol, HDL / Q000097:blood; D006801:Humans; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D015233:Models, Statistical; D017035:Pravastatin / Q000493:pharmacokinetics* / Q000494:pharmacology*; D011973:Receptors, LDL / Q000096:biosynthesis / Q000187:drug effects
chemical_list: D000924:Anticholesteremic Agents; D008076:Cholesterol, HDL; D011973:Receptors, LDL; D002784:Cholesterol; D017035:Pravastatin
references.citation: Atherosclerosis. 2011 Aug;217(2):308-21
references.pmid: 21762916
references.citation: Biochem Pharmacol. 2001 Dec 1;62(11):1545-55
references.pmid: 11728391
references.citation: J Lipid Res. 1999 Jun;40(6):1078-89
references.pmid: 10357840
references.citation: J Lipid Res. 2012 Dec;53(12):2734-46
references.pmid: 23024287
references.citation: J Pharmacol Exp Ther. 2009 Feb;328(2):652-62
references.pmid: 19001154
references.citation: J Cardiovasc Pharmacol. 2010 Oct;56(4):396-401
references.pmid: 20625310
references.citation: Am J Physiol Renal Physiol. 2007 Sep;293(3):F680-7
references.pmid: 17634396
references.citation: Am J Cardiol. 2003 Jul 15;92(2):152-60
references.pmid: 12860216
references.citation: Vascul Pharmacol. 2006 Feb;44(2):75-89
references.pmid: 16337220
references.citation: Eur J Clin Invest. 2002 Jul;32(7):528-34
references.pmid: 12153554
references.citation: Circ Cardiovasc Genet. 2009 Apr;2(2):173-81
references.pmid: 20031582
references.citation: Prog Cardiovasc Dis. 2004 Sep-Oct;47(2):73-104
references.pmid: 15586350
references.citation: Arch Intern Med. 2000 Feb 28;160(4):459-67
references.pmid: 10695686
references.citation: BMC Genomics. 2006 Jun 08;7:142
references.pmid: 16762068
references.citation: Am J Manag Care. 2005 May;11(5):306-12
references.pmid: 15898219
references.citation: J Lipid Res. 2009 Apr;50(4):730-9
references.pmid: 19043140
references.citation: Eur J Clin Nutr. 2004 Jan;58(1):1-9
references.pmid: 14679360
references.citation: Annu Rev Med. 2008;59:79-94
references.pmid: 17937591
references.citation: Lipids Health Dis. 2011 Oct 21;10:187
references.pmid: 22018353
references.citation: BMC Syst Biol. 2011 May 06;5:66
references.pmid: 21548957
references.citation: Nutr Metab Cardiovasc Dis. 2010 Jun;20(5):308-16
references.pmid: 19695854
references.citation: J Lipid Res. 2010 Jan;51(1):202-9
references.pmid: 19578163
references.citation: Nature. 2000 Sep 14;407(6801):233-41
references.pmid: 11001066
references.citation: Lancet. 2002 Jul 6;360(9326):7-22
references.pmid: 12114036
references.citation: Atherosclerosis. 2002 Sep;164(1):147-52
references.pmid: 12119203
references.citation: Circ Cardiovasc Genet. 2008 Dec;1(2):100-6
references.pmid: 20031551
references.citation: Circ Res. 2005 Jun 24;96(12):1221-32
references.pmid: 15976321
references.citation: Neth J Med. 2006 Feb;64(2):34-8
references.pmid: 16517986
references.citation: Nutr Metab Cardiovasc Dis. 2011 Oct;21(10):765-9
references.pmid: 21899991
references.citation: Biochim Biophys Acta. 2011 May;1811(5):333-42
references.pmid: 21320632
references.citation: Biopharm Drug Dispos. 1996 Dec;17(9):775-89
references.pmid: 8968530
references.citation: J Lipid Res. 2010 Apr;51(4):755-62
references.pmid: 19828909
references.citation: Nat Rev Genet. 2009 Feb;10(2):109-21
references.pmid: 19139765
references.citation: Biochim Biophys Acta. 2010 Jun;1801(6):646-54
references.pmid: 20176131
references.citation: Biochim Biophys Acta. 1995 Jan 3;1254(1):105-11
references.pmid: 7811739
references.citation: Arch Intern Med. 2006 Nov 27;166(21):2307-13
references.pmid: 17130382
references.citation: Lancet. 2010 Nov 13;376(9753):1670-81
references.pmid: 21067804
references.citation: Atherosclerosis. 1995 Oct;117(2):189-98
references.pmid: 8801864